Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Myocardial interstitial fibrosis in heart failure: biological and translational perspectives

A González, EB Schelbert, J Díez, J Butler - Journal of the American …, 2018 - jacc.org
Myocardial interstitial fibrosis contributes to left ventricular dysfunction leading to the
development of heart failure. Basic research has provided abundant evidence for the …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease

C Izumi, K Eishi, K Ashihara, T Arita, Y Otsuji… - Circulation …, 2020 - jstage.jst.go.jp
The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Calcific aortic stenosis

BR Lindman, MA Clavel, P Mathieu, B Iung… - Nature reviews Disease …, 2016 - nature.com
Calcific aortic stenosis (AS) is the most prevalent heart valve disorder in developed
countries. It is characterized by progressive fibro-calcific remodelling and thickening of the …

Extracellular matrix remodeling and cardiac fibrosis

L Li, Q Zhao, W Kong - Matrix biology, 2018 - Elsevier
Cardiac fibrosis, characterized by excessive deposition of extracellular matrix (ECM)
proteins in the myocardium, distorts the architecture of the myocardium, facilitates the …

Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin

MR Zile, CF Baicu, J S. Ikonomidis, RE Stroud… - Circulation, 2015 - Am Heart Assoc
Background—The purpose of this study was to determine whether patients with heart failure
and a preserved ejection fraction (HFpEF) have an increase in passive myocardial stiffness …

Myocardial fibrosis: biomedical research from bench to bedside

M Gyöngyösi, J Winkler, I Ramos, QT Do… - European journal of …, 2017 - Wiley Online Library
Myocardial fibrosis refers to a variety of quantitative and qualitative changes in the interstitial
myocardial collagen network that occur in response to cardiac ischaemic insults, systemic …

Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society …

Authors/Task Force Members, A Vahanian… - European heart …, 2012 - academic.oup.com
After publication, dissemination of the message is of paramount importance. Pocket-sized
versions and personal digital assistant (PDA) downloadable versions are useful at the point …